Veeco Receive Two Orders for Molecular Beam Epitaxy Systems from IPG Photonics

Veeco Instruments Inc. announced today that it has received two orders for its GEN200(TM) Molecular Beam Epitaxy (MBE) System. Both of these systems will be delivered to IPG Photonics Corporation to further expand their production of high-quality GaAs-based lasers. These orders follow IPG's purchase of its first Veeco GEN200 last year.

Dr. Alex Ovtchinnikov, Vice President-Components for IPG, stated, "We are pleased with the cost of ownership advantage and initial performance of the GEN200 System which we received in 2006 from Veeco. Veeco did an excellent job delivering and installing our first GEN200, and we have also been impressed with the ongoing service and support we are receiving. We look forward to the delivery of these two additional systems."

"Repeat orders such as these from IPG attest to the adoption of Veeco's cluster-based system for production applications, as well as the continuing, comprehensive support Veeco offers," said Jeffrey Hohn, VP/General Manager, Veeco MBE Operations. He added, "We are thrilled at the opportunity to further support IPG in their capacity expansion."

The GEN200 MBE system delivers exceptional wafer quality for lab or fab applications. Its cluster tool design provides the industry's most cost effective 4x4" epiwafer growth of devices such as pump lasers, vertical cavity surface-emitting lasers (VCSELs) and heterojunction bipolar transistors (HBTs). Its cluster tool architecture minimizes clean-room space and downtime attributed to maintenance, increases throughput; and allows for growth of different materials in connected modules.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.